Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 22, 2025 04:32 ET | Source: Research and Markets

Growth Opportunities in the Immuno-oncology Therapeutics Market, 2024-2030: Advances in Next-Gen Immunotherapies, AI, and Biomarker-Driven Personalization are Driving Transformational Growth

Dublin, Sept. 22, 2025 (GLOBE NEWSWIRE) -- The "Growth Opportunities in the Immuno-oncology Therapeutics Market, 2024-2030" report has been added to ResearchAndMarkets.com's offering. The revenue...
September 08, 2025 10:39 ET | Source: Research and Markets

Trends & Strategies in the $54 Billion PD-1 & PD-L1 Inhibitors Market 2025: Industry Revenues Will More Than Double by 2030

Dublin, Sept. 08, 2025 (GLOBE NEWSWIRE) -- The "PD-1 & PD-L1 Inhibitors Market Forecast 2025-2030" report has been added to ResearchAndMarkets.com's offering. The PD-1 & PD-L1 Inhibitors...
August 26, 2025 10:41 ET | Source: Research and Markets

Oncolytic Virotherapies Analytical Tool: Navigating the Future of Cancer Research

Dublin, Aug. 26, 2025 (GLOBE NEWSWIRE) -- The "Unlocking Opportunity: Dominate the Oncolytic Virotherapy Market with Confidence" directory has been added to ResearchAndMarkets.com's offering. The...
August 06, 2025 04:24 ET | Source: Research and Markets

Tetraspecific Antibodies Market Research 2025-2029 | Molecular Partners, Innate Pharma, and ModeX Therapeutics Lead Innovations for Oncology and Autoimmune

Dublin, Aug. 06, 2025 (GLOBE NEWSWIRE) -- The "Tetraspecific Antibodies Clinical Trials, Proprietary Technologies, Therapeutic Approaches & Market Opportunity Insight 2025" report has been added...
June 13, 2025 11:13 ET | Source: Research and Markets

Multispecific Antibodies Market, Drug Sales, Dosage, Price & Clinical Trials Report: Multispecific Antibodies Market to Surpass USD 50 Billion by 2030

Dublin, June 13, 2025 (GLOBE NEWSWIRE) -- The "Global Multispecific Antibodies Market, Drug Sales, Dosage, Price & Clinical Trials Insight 2030" report has been added to ...
May 08, 2025 05:16 ET | Source: Research and Markets

Histone Deacetylase (HDAC) 6 Pipeline Landscape 2025: In-Depth Insights Into Over 20 Companies and 26 Drugs Within the HDAC 6 Inhibitors Pipeline

Dublin, May 08, 2025 (GLOBE NEWSWIRE) -- The "Histone Deacetylase 6 - Pipeline Insight, 2025" report has been added to ResearchAndMarkets.com's offering. This report offers a detailed analysis...
April 25, 2025 04:24 ET | Source: Research and Markets

Hedgehog Pathway Inhibitors Market Report 2025: Analysis and Forecast (2020-2030) by Generic Drug, Dosage, End User, Region and Company - Featuring BridgeBio Pharma, Eli Lilly, Roche & More

Dublin, April 25, 2025 (GLOBE NEWSWIRE) -- The "Hedgehog Pathway Inhibitors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...
April 10, 2025 09:50 ET | Source: Research and Markets

Epithelioma Treatment Market Forecast and Company Analysis Report 2025-2034: Amgen, AstraZeneca, BeiGene, BMS, F. Hoffmann-La Roche, J&J, Merck, Novartis, Pfizer, Regeneron, Sanofi, Sun Pharma

Dublin, April 10, 2025 (GLOBE NEWSWIRE) -- The "Epithelioma Treatment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to ...
March 04, 2025 07:34 ET | Source: Research and Markets

AXL Inhibitors Pipeline Research Report 2025: Features Insights on 16+ Companies and 20+ Pipeline Drugs, Including Cabozantinib (Exelixis/Ipsen), BA 3011 (BioAtla) & TP-0903 (Sumitomo Dainippon Pharma Oncology)

Dublin, March 04, 2025 (GLOBE NEWSWIRE) -- The "AXL Inhibitors - Pipeline Insight, 2025" drug pipelines has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
February 18, 2025 10:29 ET | Source: Research and Markets

Bispecific Antibody Market Expands with Over 600 Clinical Trials – New Patent Analysis Report Released

Dublin, Feb. 18, 2025 (GLOBE NEWSWIRE) -- The "Bispecific Antibody & Cancer Patent Landscape Analysis" report has been added to ResearchAndMarkets.com's offering. The development of...